Pharmaceutical Manufacturing Market To Reach $990.55 Billion By 2033

Pharmaceutical Manufacturing Market Growth & Trends

The global pharmaceutical manufacturing market size is expected to reach USD 990.55 billion by 2033, registering a CAGR of 5.88% from 2026 to 2033, according to a new report by Grand View Research, Inc. The pharmaceutical industry has undergone significant transformations as a result of technological advancements, cost-effective methods, and increased investments. These factors have had a positive impact on the growth of the market. The implementation of robotic technology and Artificial Intelligence (AI) has played a crucial role in reducing manufacturing floor downtime and minimizing product waste. By incorporating these technologies, efficiency, and productivity in pharmaceutical manufacturing processes have been greatly improved.

In addition, traditional open-transfer manufacturing methods have been replaced by the adoption of single-use disposable solutions, leading to streamlined operations and reduced risks of contamination. Moreover, there has been a notable shift toward integrated, smart, and data-rich paperless operations within the industry. This transition has resulted in error-free and precise production processes, ensuring the production of high-quality pharmaceutical products. These ongoing advancements in the market have significantly contributed to the progress of drug manufacturing. The development of personalized medicine has brought about a revolution in the healthcare sector, offering new opportunities to target various health conditions and paving the way for patient-centric models.

Consequently, there has been a shift from large-scale production to smaller batches to cater to the development of complex medicines and personalized treatments tailored to individual patients. This transformative shift has prompted manufacturers to restructure their supply chains in alignment with the patient-centric healthcare system. All such factors propel pharmaceutical manufacturing market growth over the forecast period. Furthermore, leading companies in the pharmaceutical industry have taken strategic initiatives to enhance their market presence and gain a competitive advantage. These key players actively engage in various activities, such as product development, collaboration & partnership models, agreements, business expansion, and merger & acquisition strategies.

These initiatives are also aimed at strengthening their product portfolios and meeting the growing demand for pharmaceutical products. For instance, in April 2022, Ferring Pharmaceuticals inaugurated an integrated manufacturing and research and development (R&D) facility in Hyderabad, India. This facility underscores Ferring's commitment to expanding its operations and capabilities. The R&D division of the facility focuses on areas, such as packaging development, formulation development, and analytical development. Ferring Pharmaceuticals aims to enhance its product offerings and meet the evolving needs of the market by investing in these areas.

 Request a free sample copy or view report summary: Pharmaceutical Manufacturing Market Report

Pharmaceutical Manufacturing Market Report Highlights

• By molecule type, the conventional drugs (small molecules) segment held the highest market share of 56.17% in 2025. The biologics & biosimilars (large molecules) segment is projected to grow at a significant CAGR during the forecast period.

• By drug development, the outsourced segment dominated the market in 2025. The in-house segment is crucial for large pharmaceutical companies that require full control over their intellectual property, product quality, and regulatory compliance.

• By formulations, the injectables segment held the largest revenue share of 25.92% in 2025. The sprays segment is expected to grow at the fastest CAGR during the forecast period.

• By route of administration, the oral segment dominated the market in revenue in 2025. The parenteral segment is growing at the fastest CAGR over the forecast period.

• By therapy area, the other diseases segment accounted for the largest revenue share of 61.83% in 2025. The respiratory diseases segment is expected to grow at the fastest CAGR over the forecast period.

• By prescription, the prescription medicine segment held the largest revenue share in 2025. The over-the-counter (OTC) medicines segment is growing steadily in the coming years.

• By age group, the geriatric segment dominated the market in 2025. The children & adolescents segment is expected to grow rapidly over the forecast period.

• By sales channel, the retail segment dominated the market and accounted for a revenue share in 2025. The non-retail segment, which covers hospital pharmacies, clinics, and specialty care centers, is growing as more people need advanced therapies and complex treatments.

Pharmaceutical Manufacturing Market Segmentation

Grand View Research has segmented the global pharmaceutical manufacturing market report based on molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and region:

Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Billion, 2021 - 2033)

• Biologics & Biosimilars (Large Molecules)

  • Monoclonal Antibodies

  • Vaccines

  • Cell & Gene Therapy

  • Others

• Conventional Drugs (Small Molecules)

Pharmaceutical Manufacturing Drug Development Outlook (Revenue, USD Billion, 2021 - 2033)

• In-house

• Outsource

Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Billion, 2021 - 2033)

• Tablets

• Capsules

• Injectable

• Sprays

• Suspensions

• Powders

• Other Formulations

Pharmaceutical Manufacturing Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)

• Oral

• Topical

• Parenteral

• Inhalations

• Other Routes of Administration

Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Billion, 2021 - 2033)

• Cardiovascular Diseases (CVDs)

• Pain

• Diabetes

• Cancer

• Respiratory Diseases

• Other Diseases

Pharmaceutical Manufacturing Prescription Outlook (Revenue, USD Billion, 2021 - 2033)

• Prescription Medicines

• Over-the-counter (OTC) Medicines

Pharmaceutical Manufacturing Age Group Outlook (Revenue, USD Billion, 2021 - 2033)

• Children & Adolescents

• Adults

• Geriatric

Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Billion, 2021 - 2033)

• Retail

• Non-retail

Pharmaceutical Manufacturing Regional Outlook (Revenue, USD Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the Pharmaceutical Manufacturing Market

• F. Hoffmann-La Roche Ltd.

• Novartis AG

• GSK plc

• Pfizer, Inc.

• Merck & Co., Inc.

• AstraZeneca

• Johnson & Johnson

• Sanofi SA

• Eli Lilly and Company

• AbbVie, Inc.

• Thermo Fisher Scientific, Inc.

• Wuxi Apptec

• Samsung Biologics

• FUJIFILM Biotechnologies

• Lonza

• Catalent, Inc.

• Jubilant Pharmova Limited